About Ivantis
Ivantis is a Technology company based in Irvine (United States) founded in 2007, and was acquired by Alcon in November 2021. Implantable device to relieve intraocular pressure in open angle glaucoma. It operates in the Technology and Healthcare sectors. Ivantis has raised $166.23 million across 7 funding rounds from investors including Alcon, RA Capital and Merieux Equity Partners. The company has 132 employees. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is IVANTIS, INC. Its competitors include Glaukos, Myra Vision and Transcend Medical; 3 of its 3 listed competitors have raised funding.
Company details
Ivantis Inc. was founded in 2007 in Irvine, United States, focusing on medical devices for ophthalmology. Solutions for primary open-angle glaucoma are developed by the company, including an intracanalicular scaffold designed as an implantable device. High intraocular pressures in patients are addressed through this technology. Operations center on innovation in glaucoma treatment, with the domain ivantisinc.com serving as the primary online presence.
- Headquarters Irvine, United States
- Employees 132
- Stage Acquired
- SectorsTechnologyHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website ivantisinc.com
- Social LinkedIn X
- Acquired by Alcon (Nov 2021)
- Legal Name Ivantis, Inc.
Funding Insights of Ivantis
Ivantis has successfully raised a total of $166.23M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $166.23M
- Total Rounds 7
- Last Round Series C β $25M
- First Round $19.1M
(Jun 2008)
- Investors Count 10
All 7 funding rounds of Ivantis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $25M | Series C | β | RA Capital Management | |
| Oct 2014 | $58.87M | Series C | β | GBS, Vertex Ventures HC | |
| Jan 2014 | $14M | Series B | β | β | |
| Aug 2013 | $5M | Series B | β | β | |
| Feb 2013 | $27M | Series B | β | Ascension Ventures | |
| May 2011 | $17.26M | Series B | β | New Enterprise Associates, Delphi Ventures | β |
| Jun 2008 | $19.1M | Series A | β | β | β |
11 investors in total: 11 institutional.
Investors in Ivantis
Ivantis has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, RA Capital and Merieux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pivate equity firm that focuses on investing in healthcare and nutrition companies | merieux-partners.com | Lyon, France | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Investments are made in life sciences firms across all stages. | delphiventures.com | Menlo Park, United States | ||
Early & Growth stage life sciences & tech focused VC firm investing primarily in the US | memorialcareinnovationfund.com | Long Beach, United States | ||
| gbsventures.com.au | ||||
Multi-stage investment firm invests in healthcare and life sciences companies | foresitecapital.com | New York, United States | ||
Government-backed investments are directed toward healthcare, fintech, and various sectors. | edbi.com | Singapore, Singapore | ||
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
| vertexventureshc.com | ||||
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States |
Investor details for Ivantis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ivantis
4 dated milestones of Ivantis across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Ivantis is founded.
- Funding First funding round of $19.1M.
- Funding Latest funding round, Series C, of $25.0M.
- Exit Acquired by Alcon.
Competitors of Ivantis
Ivantis has 3 listed competitors in our database, 3 of them funded. They include Glaukos, Myra Vision and Transcend Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glaukos.com | 2001 | Laguna Hills, United States | $117.57M | 907 | Developer of implants to treat glaucoma | |
| myravision.com | 2019 | Campbell, United States | $42M | Nanotechnology-based devices for glaucoma treatment are developed. | ||
| transcendmedical.com | 2006 | Menlo Park, United States | $122.27M | 20 | Minimally invasive glaucoma stents are developed to enhance aqueous outflow. |
Detailed competitors of Ivantis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Sensors & Smart Devices
3 companies that operate in the same segment as Ivantis (Sensors & Smart Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
VR-based head-mounted displays for gaming are provided by Oculus. | 2012 | Menlo Park, California, United States | USD 107.05 M | |||
Cloud-based business telephony and home security services are provided. | 2004 | Palo Alto, California, United States | USD 87.97 M | USD 273.6 M | 1,190 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ivantis
Complete news archive for Ivantis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ivantis
Ivantis was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Ivantis is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Ivantis is a funded company, having raised a total of $166.23M across 7 funding rounds to date. The company's 1st funding round was a Series A of $19.1M, raised on Jun 2008.
Ivantis has 132 employees.
Ivantis Inc. was founded in 2007 in Irvine, United States, focusing on medical devices for ophthalmology. Solutions for primary open-angle glaucoma are developed by the company, including an intracanalicular scaffold designed as an implantable device. High intraocular pressures in patients are addressed through this technology. Operations center on innovation in glaucoma treatment, with the domain ivantisinc.com serving as the primary online presence.
Ivantis's top competitors include Glaukos, Myra Vision and Transcend Medical.
Ivantis has 11 investors. Key investors include Alcon, RA Capital, Merieux Equity Partners, NEA, and Delphi Ventures.
Ivantis operates through Ivantis, Inc..
Yes. Ivantis was acquired by Alcon in November 2021.

